Method and dosage form using an antagonist to gamma...

Details Method and dosage form using an antagonist to gamma... Method and dosage form using an antagonist to gamma...

A - Human Necessities

61

K

167/139

A61K 39/395 (2006.01) C07K 16/24 (2006.01) A61K 38/00 (2006.01)

Patent

CA 1335792

Diseases associated with MHC-linked immune response genes are controlled through immunosuppression of the immune response by administering an antagonist of gamma interferon to individuals who are susceptible to or who have an MHC-linked autoimmune disease. More specifically, treatment with antibodies directed against IFN-.gamma. delays and alleviates the symptoms of MHC-linked autoimmune diseases in mammals.

574779

Affiliated with

Also associated with

Rating

Method and dosage form using an antagonist to gamma... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method and dosage form using an antagonist to gamma..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and dosage form using an antagonist to gamma... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1276330